SSA
ORGO icon

Schonfeld Strategic Advisors’s Organogenesis Holdings ORGO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.6K Buy
+25,747
New +$62.9K ﹤0.01% 2357
2023
Q3 		– Sell
-17,000
Closed -$56.4K – 2152
2023
Q2 		$56.4K Buy
+17,000
New +$50.2K ﹤0.01% 1801
2022
Q2 		– Sell
-78,316
Closed -$597K – 2873
2022
Q1 		$597K Buy
+78,316
New +$606K 0.01% 1260
2021
Q1 		– Sell
-137,700
Closed -$1.04M – 2042
2020
Q4 		$1.04M Buy
+137,700
New +$654K 0.01% 802

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Schonfeld Strategic Advisors's ORGO Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 25,747 shares worth $62.6K. The stake represents ﹤0.01% of the portfolio and ranks #2357 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in ORGO as recently as Q2 2023.

Schonfeld Strategic Advisors first reported a position in ORGO in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.04M in Q4 2020. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Schonfeld Strategic Advisors held 25,747 shares of Organogenesis Holdings worth $62.6K as of Q2 2026.
  • Organogenesis Holdings was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2357 holding.
  • Schonfeld Strategic Advisors first reported a position in Organogenesis Holdings in Q4 2020 and has held it in 4 quarters since.
  • Schonfeld Strategic Advisors's Organogenesis Holdings position peaked at $1.04M in Q4 2020.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.